Abstract
In this paper we describe a comparative analysis between multivariate and docking methods in the study of the drug resistance to the reverse transcriptase and the protease inhibitors. In our early papers we developed a simple but efficient method to evaluate the features of compounds that are less likely to trigger resistance or are effective against mutant HIV strains, using the multivariate statistical procedures PCA and DA. In the attempt to create a more solid background for the prediction of susceptibility or resistance, we carried out a comparative analysis between our previous multivariate approach and molecular docking study. The intent of this paper is not only to find further support to the results obtained by the combined use of PCA and DA, but also to evidence the structural features, in terms of molecular descriptors, similarity, and energetic contributions, derived from docking, which can account for the arising of drug-resistance against mutant strains.







Similar content being viewed by others
Abbreviations
- NNRTIs:
-
Non-nucleoside reverse transcriptase inhibitors
- PIs:
-
Protease inhibitors
- PR:
-
Protease
- RT:
-
Reverse transcriptase
References
Hammer S, Vaida F, Bennett K, Holohan M, Sheiner L, Eron J, Wheat L, Mitsuyasu R, Gulick R, Valentine F, Aberg J, Rogers M, Karol C, Saah A, Lewis R, Bessen L, Brosgart C, DeGruttola V, Mellors J (2002) J Am Med Assoc 288:169
Gallant J (2000) J Am Med Assoc 283:1329
Carpenter C, Cooper D, Fischl M, Gatell J, Gazzard B, Hammer S, Hirsch M, Jacobsen D, Katzenstein D, Montaner J, Richman D, Saag M, Schechter M, Schooley R, Thompson M, Vella S, Yeni P, Volberding P (2000) J Am Med Assoc 283:381
Hirsch M, Richman D (2000) J Am Med Assoc 284:1649
Rusconi S, La Seta Catamancio S, Sheridan F, Parker D (2000) J Clin Virol 19:135
Holodniy M, Katzenstein D, Winters M, Montoya J, Shafer R, Kozal M, Ragni M, Merigan T (1993) J Acquir Immune Defic Syndr 6:366
Schuurman R, Demeter L, Reichelderfer P, Tijnagel J, de Groot T, Boucher C (1999) J Clin Microbiol 37:2291
Race E, Gilbert S, Sheldon J, Rose J, Moffatt A, Sitbon G, Dissanayeke S, Cammack N, Duncan I (1998) AIDS 12:1465
Shafer R (2002) Clin Microbiol Rev 15:247
Schinazi R, Larder B, Mellors J (2000) Int Antiv News 8:65
Baxter J, Mayers D, Wentworth D, Neaton J, Hoover M, Winters M, Mannheimer S, Thompson M, Abrams D, Brizz B (2000) AIDS 14:F83
Holloway M, Wai J, Halgren T, Fitzgerald P, Vacca J, Dorsey B, Levin R, Thompson W, Chen L, deSolms S (1995) J Med Chem 38:305
Nair A, Jayatilleke P, Wang X, Miertus S, Welsh W (2002) J Med Chem 45:973
Perez C, Pastor M, Ortiz A, Gago F (1998) J Med Chem 41:836
Shenderovich M, Kagan R, Heseltine P, Ramnarayan K (2003) Protein Sci 12:1706
Jenwitheesuk E, Samudrala R (2005) Antivir Ther 10:157
Almerico AM, Lauria A, Tutone M, Diana P, Barraja P, Montalbano A, Cirrincione G, Dattolo G (2003) QSAR Comb Sci 22:984
Almerico AM, Tutone M, Lauria A, Diana P, Barraja P, Montalbano A, Cirrincione G, Dattolo G (2006) J Chem Inf Model 46:168
All of the calculations were run on a Silicon Graphics Indigo II workstation using the software TSAR 3.2 (Tools for Structure Activity Relationships), VAMP 6.0, and ASP 3.2 (Automated Similarity Packages) (Oxford Molecular-Accelrys). Molecular descriptors were derived according to the method and assumptions reported in the TSAR 3.2 Reference Guide, Oxford Molecular Limited (1998)
Ligandfit User Manual, Accelrys Inc (2003)
Venkatachalam C, Jiang X, Oldfield T, Waldman M (2003) J Mol Graph Model 21:289
Böhm H (1998) J Comput Aided Mol Des 12:309
Verkhivker G, Bouzida D, Gehlhaar D, Rejto P, Arthurs S, Colson A, Freer S, Larson V, Luty B, Marrone T, Rose P (2000) J Comput Aided Mol Des 14:731
Gehlhaar D, Verkhivker G, Rejto P, Sherman C, Fogel D, Fogel L, Freer S (1995) Chem Biol 2:317
Muegge I, Martin Y (1999) J Med Chem 42:791
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Rights and permissions
About this article
Cite this article
Almerico, A.M., Tutone, M. & Lauria, A. Docking and multivariate methods to explore HIV-1 drug-resistance: a comparative analysis. J Comput Aided Mol Des 22, 287–297 (2008). https://doi.org/10.1007/s10822-008-9186-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10822-008-9186-7